
Axsome Therapeutics, Inc. (AXSM) engages in the development of novel therapies for central nervous system (CNS) disorders. Johnson & Johnson (JNJ) develops, manufactures, and sells various products in the healthcare field worldwide.
An aging population and rising chronic diseases are expected to drive the pharmaceutical sector’s growth. Moreover, the integration of advanced technologies in the drug development process and early detection of diseases should propel the industries’ growth.